Increased TGFβ type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells

Alessandra Turco, Susanna Scarpa, Anna Coppa, Gianluca Baccheschi, Camilla Palumbo, Carlo Leonetti, Gabriella Zupi, Giulia Colletta

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

TGFβ can modulate neuroblastoma (NB) cell proliferation and differentiation in vitro. In this study we used a NB cell line (LAN-5) which has been shown to partially respond to TGFβ and to present high levels of TGFβ receptor type I and low levels of receptor type II (TβRII) on the cell surface. To evaluate the role of TβRII in mediating TGFβ effects, LAN-5 cells were transfected with an expression vector containing the human full- length TβRII cDNA or with the empty vector pcDNA3. Compared to control CLV3 cells (transfected with empty plasmid) and parental LAN-5 cells, isolated neomycin-resistant clones (CL1 and CL3) expressed higher levels of TβRII, had reduced cell growth rate in vitro, and were unable to form tumors in vivo. Furthermore, isolated clones modified their morphology, assuming a terminally differentiated neuronal phenotype. Immunocytochemical staining demonstrated a basal increased expression of neural-specific markers, such as axonal growth-associated protein (GAP43) and neurofilaments (NF200). TGFβ treatment further increased the synthesis of NF200 and GAP43 in the transfected clones as revealed by Western blot analysis. These data indicate that TβRII overexpression potentiates the TGFβ signal transduction pathway, reverting NB cell neoplastic phenotype with the reduction of proliferation rate and the induction of terminal maturation. (C) 2000 Academic Press.

Original languageEnglish
Pages (from-to)77-85
Number of pages9
JournalExperimental Cell Research
Volume255
Issue number1
DOIs
Publication statusPublished - Feb 25 2000

Fingerprint

Neuroblastoma
Local Area Networks
Phenotype
Clone Cells
GAP-43 Protein
Neurofilament Proteins
Neomycin
Growth
Cell Differentiation
Signal Transduction
Plasmids
Complementary DNA
Western Blotting
Cell Proliferation
Staining and Labeling
Cell Line
Neoplasms

Keywords

  • Neuroblastoma cells
  • Neuronal markers
  • TβRII
  • TGFβ

ASJC Scopus subject areas

  • Cell Biology

Cite this

Increased TGFβ type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells. / Turco, Alessandra; Scarpa, Susanna; Coppa, Anna; Baccheschi, Gianluca; Palumbo, Camilla; Leonetti, Carlo; Zupi, Gabriella; Colletta, Giulia.

In: Experimental Cell Research, Vol. 255, No. 1, 25.02.2000, p. 77-85.

Research output: Contribution to journalArticle

Turco, Alessandra ; Scarpa, Susanna ; Coppa, Anna ; Baccheschi, Gianluca ; Palumbo, Camilla ; Leonetti, Carlo ; Zupi, Gabriella ; Colletta, Giulia. / Increased TGFβ type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells. In: Experimental Cell Research. 2000 ; Vol. 255, No. 1. pp. 77-85.
@article{fe2d79255b7843858b48ccf477a504bf,
title = "Increased TGFβ type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells",
abstract = "TGFβ can modulate neuroblastoma (NB) cell proliferation and differentiation in vitro. In this study we used a NB cell line (LAN-5) which has been shown to partially respond to TGFβ and to present high levels of TGFβ receptor type I and low levels of receptor type II (TβRII) on the cell surface. To evaluate the role of TβRII in mediating TGFβ effects, LAN-5 cells were transfected with an expression vector containing the human full- length TβRII cDNA or with the empty vector pcDNA3. Compared to control CLV3 cells (transfected with empty plasmid) and parental LAN-5 cells, isolated neomycin-resistant clones (CL1 and CL3) expressed higher levels of TβRII, had reduced cell growth rate in vitro, and were unable to form tumors in vivo. Furthermore, isolated clones modified their morphology, assuming a terminally differentiated neuronal phenotype. Immunocytochemical staining demonstrated a basal increased expression of neural-specific markers, such as axonal growth-associated protein (GAP43) and neurofilaments (NF200). TGFβ treatment further increased the synthesis of NF200 and GAP43 in the transfected clones as revealed by Western blot analysis. These data indicate that TβRII overexpression potentiates the TGFβ signal transduction pathway, reverting NB cell neoplastic phenotype with the reduction of proliferation rate and the induction of terminal maturation. (C) 2000 Academic Press.",
keywords = "Neuroblastoma cells, Neuronal markers, TβRII, TGFβ",
author = "Alessandra Turco and Susanna Scarpa and Anna Coppa and Gianluca Baccheschi and Camilla Palumbo and Carlo Leonetti and Gabriella Zupi and Giulia Colletta",
year = "2000",
month = "2",
day = "25",
doi = "10.1006/excr.1999.4750",
language = "English",
volume = "255",
pages = "77--85",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Increased TGFβ type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells

AU - Turco, Alessandra

AU - Scarpa, Susanna

AU - Coppa, Anna

AU - Baccheschi, Gianluca

AU - Palumbo, Camilla

AU - Leonetti, Carlo

AU - Zupi, Gabriella

AU - Colletta, Giulia

PY - 2000/2/25

Y1 - 2000/2/25

N2 - TGFβ can modulate neuroblastoma (NB) cell proliferation and differentiation in vitro. In this study we used a NB cell line (LAN-5) which has been shown to partially respond to TGFβ and to present high levels of TGFβ receptor type I and low levels of receptor type II (TβRII) on the cell surface. To evaluate the role of TβRII in mediating TGFβ effects, LAN-5 cells were transfected with an expression vector containing the human full- length TβRII cDNA or with the empty vector pcDNA3. Compared to control CLV3 cells (transfected with empty plasmid) and parental LAN-5 cells, isolated neomycin-resistant clones (CL1 and CL3) expressed higher levels of TβRII, had reduced cell growth rate in vitro, and were unable to form tumors in vivo. Furthermore, isolated clones modified their morphology, assuming a terminally differentiated neuronal phenotype. Immunocytochemical staining demonstrated a basal increased expression of neural-specific markers, such as axonal growth-associated protein (GAP43) and neurofilaments (NF200). TGFβ treatment further increased the synthesis of NF200 and GAP43 in the transfected clones as revealed by Western blot analysis. These data indicate that TβRII overexpression potentiates the TGFβ signal transduction pathway, reverting NB cell neoplastic phenotype with the reduction of proliferation rate and the induction of terminal maturation. (C) 2000 Academic Press.

AB - TGFβ can modulate neuroblastoma (NB) cell proliferation and differentiation in vitro. In this study we used a NB cell line (LAN-5) which has been shown to partially respond to TGFβ and to present high levels of TGFβ receptor type I and low levels of receptor type II (TβRII) on the cell surface. To evaluate the role of TβRII in mediating TGFβ effects, LAN-5 cells were transfected with an expression vector containing the human full- length TβRII cDNA or with the empty vector pcDNA3. Compared to control CLV3 cells (transfected with empty plasmid) and parental LAN-5 cells, isolated neomycin-resistant clones (CL1 and CL3) expressed higher levels of TβRII, had reduced cell growth rate in vitro, and were unable to form tumors in vivo. Furthermore, isolated clones modified their morphology, assuming a terminally differentiated neuronal phenotype. Immunocytochemical staining demonstrated a basal increased expression of neural-specific markers, such as axonal growth-associated protein (GAP43) and neurofilaments (NF200). TGFβ treatment further increased the synthesis of NF200 and GAP43 in the transfected clones as revealed by Western blot analysis. These data indicate that TβRII overexpression potentiates the TGFβ signal transduction pathway, reverting NB cell neoplastic phenotype with the reduction of proliferation rate and the induction of terminal maturation. (C) 2000 Academic Press.

KW - Neuroblastoma cells

KW - Neuronal markers

KW - TβRII

KW - TGFβ

UR - http://www.scopus.com/inward/record.url?scp=0034711879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034711879&partnerID=8YFLogxK

U2 - 10.1006/excr.1999.4750

DO - 10.1006/excr.1999.4750

M3 - Article

VL - 255

SP - 77

EP - 85

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 1

ER -